Patient involvement in consultation for atrial fibrillation - the cardiologists' perspective

Ulla Hellström Muhli1, Jan Trost1, Eleni Siouta2,3

  • 1Department of Sociology, Uppsala University , Uppsala, Sweden.

Insights

Swedish cardiologists describe patient involvement in atrial fibrillation (AF) consultations through various practices. True shared decision-making requires equal power, which is challenging to achieve in clinical settings.

Area of Science:

  • Cardiology
  • Medical Sociology
  • Health Services Research

Background:

  • Patient involvement in medical consultations is increasingly recognized as crucial for effective treatment.
  • Shared decision-making (SDM) aims to align treatment plans with patient values and preferences.
  • Understanding healthcare providers' perspectives is key to improving patient engagement.

Purpose of the Study:

  • To analyze how Swedish cardiologists perceive and implement patient involvement in atrial fibrillation (AF) consultations.
  • To explore cardiologists' understanding and familiarity with the concept of shared decision-making (SDM).

Main Methods:

  • A descriptive qualitative study design was employed.
  • Semi-structured interviews were conducted with ten cardiologists across four Swedish hospitals.
  • Qualitative content analysis was used to analyze interview data.

Main Results:

  • Cardiologists described patient involvement using themes of persuasive practice, protective practice, professional role, and medical craftsmanship.
  • "Shared decision-making" was understood as reaching a mutually satisfactory agreement.
  • The ideal of equal power between patient and cardiologist for SDM is difficult to guarantee in practice.

Conclusions:

  • Descriptive qualitative content analysis effectively revealed cardiologists' perspectives on patient involvement and SDM.
  • Cardiologists should prioritize patient involvement in AF treatment decisions to meet patient expectations.
  • Recognizing patients as active participants is fundamental for successful patient involvement and SDM.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...